Introduction Knee osteoarthritis often starts in the patellofemoral compartment and is diagnosed
in about 39% of people with knee pain aged above 30 years. Nasal chondrocyte Tissue
Engineered Cartilage (N-TEC) has been successfully introduced in phase I and II clinical
studies for the treatment of focal cartilage lesions, and in a pilot group of patients
with osteoarthritis. However, no consensus for treatment recommendation for isolated
patellofemoral osteoarthritis (PFOA) in clinical guidelines exist.
Objective To develop two physiotherapy-based postintervention rehabilitation protocols (PPRPs)
following the implantation of N-TEC and the comparator platelet-rich plasma (PRP)
injections in patients with PFOA.
Methods For a randomised controlled trial (RCT) involving 75 patients with PFOA from nine
different clinical centres in Switzerland, Germany and Croatia two PPRPs based on
the current literature on cartilage transplantation or PRP injections and osteoarthritis
were developed. In addition, results from a pilot study and expert opinions from physiotherapist
and physicians were incorporated. All physiotherapists involved in the study receive
a 30-minute standardised training in the application of the protocols.
Results Our work explains the two different PPRPs, including the distinct rehabilitation
phases with their respective goals, interventions, and milestones. Both PPRPs focus
on pain reduction, muscle strengthening (knee and hip muscles), proprioceptive training,
optimizing neuromuscular function and patient education but they will differ during
the initial phase (12 weeks):
N-TEC group: The PPRP protects the implanted graft during the early postoperative phase. Protective
measures include six weeks of partial weight-bearing with crutches and 12 weeks of
restricted knee motion post-surgery.
PRP group: The primary objective is to prevent excessive loading of the painful knee joint.
Therefore, therapeutic exercises involving knee movements against maximal resistance
during extension and flexion, as well as those incorporating rotational components
or performed in high-stress positions, such as kneeling, are not recommended. Additionally,
physiotherapy is not advised within the first three days following injection.
Conclusion Both detailed PPRPs enable standardised treatment of study participants while accounting
for individual patient-specific factors. In the future, both PPRPs aim to support
optimal postintervention care for patients undergoing N-TEC transplantation or PRP
injections in the patellofemoral joint.